It has been previously shown that while the 5-HT1A receptor agonist 8-hydroxy-2-(di-N-propylamino)- Male Wistar rats (n=32, b.wt. 260 - 300g) were fasted for 22h, and injected with either saline followed by saline (n=8), saline followed by 8-OH-DPAT (50 μg kg-1; n=8), the 5-HT1A receptor antagonist WAY 100635 (0.3 mg kg-1) followed by saline (n=8), WAY 100635 (0.3 mg kg-1) followed by 8-OH-DPAT (50 μg kg-1; n=8). Both injections were given s.c.; 30 min separated the 2 injections. Immediately after the second injection, the rats were placed separately in experimental cages with access to food. Food consumption was measured at intervals over 120 min, as described previously (Ebenezer, 1990). The data were analysed by two-way ANOVA and post-hoc Dunnett’s test. The results are illustrated in Fig. 1. In agreement with previous results, 8-OH-DPAT (50 μg kg-1) significantly reduced food intake in the fasted rats (Ebenezer, 1990). The selective 5-HT1A receptor antagonist WAY 100635 (Fletcher et al., 1996) had no effect on food intake. However, pretreatment with WAY 100635 (0.3 mg kg-1) completely abolished the hypophagic effect of 8-OH-DPAT. The results of this study extend previous observations and suggest that the suppressant effect of 8-OH-DPAT on food intake in food-deprived rats is mediated by an action at 5-HT1A receptors. Fig. 1. The effect of WAY100635 (0.3 mg kg-1) on the hypophagic effect of 8-OH-DPAT (50 μg kg-1; DPAT) in 22h food-deprived rats. Vertical line rep. + s.e.mean. Ebenezer, I.S. (1990) NeuroReport, 1, 73 – 76. |